©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Respirol. Feb 20, 2019; 9(3): 30-34
Published online Feb 20, 2019. doi: 10.5320/wjr.v9.i3.30
Published online Feb 20, 2019. doi: 10.5320/wjr.v9.i3.30
Diagnosis and treatment of subsegmental pulmonary embolism
Michael Newnham, Alice M Turner, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom
Author contributions: Newnham M and Turner AM wrote the editorial and both authors approved the final version of the article.
Conflict-of-interest statement: The authors have no conflict of interest to declare.
Corresponding author: Michael Newnham, MBChB, MRCP, MSc, Doctor, Lecturer, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom. michaelnewnham@nhs.net
Telephone: +44-121-3713885
Received: December 3, 2018
Peer-review started: December 4, 2018
First decision: January 4, 2019
Revised: January 10, 2019
Accepted: January 28, 2019
Article in press: January 28, 2019
Published online: February 20, 2019
Processing time: 78 Days and 19.3 Hours
Peer-review started: December 4, 2018
First decision: January 4, 2019
Revised: January 10, 2019
Accepted: January 28, 2019
Article in press: January 28, 2019
Published online: February 20, 2019
Processing time: 78 Days and 19.3 Hours
Core Tip
Core tip: Current guidelines suggest that isolated subsegmental pulmonary embolism (SSPE) patients at low risk of venous thromboembolism (VTE) recurrence and without concurrent proximal VTE can be followed up with clinical surveillance in preference to anticoagulation. This is based on limited evidence and a randomised controlled trial is required to determine the risks and benefits of anticoagulation in SSPE.